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Summary 
The aim of the present study was to characterize intraventricular 
pressure gradients (IVPGs) in an animal model of chronic heart 
failure. New Zealand rabbits were treated with doxorubicin (heart 
failure group, n=5) or saline (control group, n=5) and 
instrumented with pressure catheters placed in the apex and 
outflow-tract of left ventricle (LV) and with sonomicrometer 
crystals placed in the apex and base of the LV free wall. In heart 
failure animals, ventricular filling was delayed and slower when 
compared with control animals. Moreover, the physiological 
nonuniformity observed between apical and basal segments in 
normal hearts was abolished in failing hearts. Simultaneously, 
physiological IVPGs observed during normal ventricular filling 
were entirely lost in heart failure animals. During ventricular 
emptying physiological nonuniformity between apical and basal 
segments observed in control animals was also abolished in heart 
failure animals. In failing hearts minimal length occurred later 
and almost at same time both in apical and in basal myocardial 
segments. Simultaneously, the characteristic IVPG pattern 
observed in healthy hearts during systole, which promotes 
ventricular emptying, was not observed in failing hearts. The 
present study showed that diastolic IVPGs, a marker of normal 
ventricular filling, and systolic IVPGs, a marker of normal 
ventricular emptying, are abolished in heart failure. 
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Introduction 
 
Courtois et al. (1988) described for the first 
time, in a canine model, intraventricular pressure 
gradients (IVPGs) during diastole and later showed that 
these diastolic gradients were diminished by ischemia and 
related to systolic function (Courtois et al. 1990). 
Recently, we extended those observations also in an 
animal model. We confirmed not only the existence of 
diastolic but also systolic IVPGs in the left ventricle (LV) 
and demonstrated, for the first time, that they are 
modulated by physiological nonuniformity (Brutsaert et 
al. 1987) between basal and apical myocardial segments 
(Guerra et al. 2013). Moreover, we showed that diastolic 
and systolic IVPGs, a marker of normal segmental 
function, can be attenuated, lost entirely or even reversed 
when ventricular emptying is opposed by afterload 
elevations or after regional acute ischemia (Guerra et al. 
2013). 
Furthermore, Firstenberg et al. (2008) showed 
that improvements in LV systolic and diastolic function, 
through surgical myocardial revascularization in patients 
with ischemic cardiomyopathy, correlate directly with the 
recovery of diastolic IVPGs. Rovner et al. (2005) also 
demonstrated that diastolic IVPGs augmentation and LV 
relaxation improvement with exercise are significantly 
impaired in heart failure patients. However, systolic and 
diastolic IVPGs were never carefully observed and 
characterized, namely their magnitude and their behavior 
in the presence of systolic and/or diastolic dysfunction, in 
chronic models of heart failure (Stugaard et al. 1993, 
Steine et al. 2002). 
In fact, the practical value of IVPGs in 
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understanding ventricular pathophysiology is enhanced 
by the recognition of its general applicability and 
quantification not only in acute models, but also in 
chronic models (De Boeck et al. 2005, Yotti et al. 
2005a,b). Diastolic and systolic IVPGs may reflect 
intrinsic properties and chronic dysfunction of the LV 
and not only an acute transvalvular flow disorder 
(Firstenberg et al. 2001, Guerra et al. 2011b). In this 
setting, the present study was conducted to characterize 
diastolic and systolic IVPGs in an animal model of 
chronic heart failure, and correlate IVPGs with diastolic 
and systolic segmental LV dysfunction and 
nonuniformity. 
 
Methods 
 
The investigation conforms to the Guide for the 
Care and Use of Laboratory Animals published by the US 
National Institutes of Health (NIH publication no. 85-23, 
Revised 1996), and all animals received human care in 
compliance with the European Convention on Animal 
Care. Study was also approved by the Ethics Committee 
of our University. 
 
Chronic heart failure model 
A well-documented regimen was used for the 
induction of heart failure due to doxorubicin toxicity 
(Arnolda et al. 1985, Brás-Silva et al. 2008). Adult male 
New Zealand White rabbits (Oryctolagus cuniculus, 
3.0±0.2 kg) received doxorubicin via a marginal ear vein 
by bolus injection (1 mg/kg) twice weekly for 8 weeks 
(n=5) followed by a washout period of 1 week. Control 
rabbits (n=5) received the vehicle (0.9 % saline) in 
equivolumetric doses over the same period. All animals 
were evaluated by echocardiography at the beginning and 
every two weeks during the administration of doxorubicin 
or vehicle. Echocardiographic examination was 
performed as previously described (Fontes-Sousa et al. 
2009). Briefly, the rabbits were lightly anesthetized with 
an intramuscular combination of ketamine hydrochloride 
(2 mg/kg) and medetomidine hydrochloride (0.15 mg/kg), 
being allowed to breath spontaneously. The animals were 
placed prone on a table with an area removed so that the 
ultrasound probe could be brought from below and 
placed on a shaved area of the anterior chest wall. 
The echocardiograms were obtained using a 7.5 MHz 
transducer (Vivid 3 General Electrics echocardiograph, 
Portugal) and the examination was performed from the 
right parasternal short-axis view. Two-dimensional 
guided M-mode tracings were made just below the mitral 
valve at the level of the papillary muscles for 
measurements of the left ventricular internal diameter and 
the left ventricular wall was free in diastole and systole. 
Three representative cycles were measured and averaged 
for each rabbit at each time point. Analyzed parameters 
were: heart rate, anterior and posterior end-diastolic and 
end-systolic wall thickness, left ventricular end-systolic 
and end-diastolic diameters, and fractional shortening. 
 
Experimental preparation 
Animal preparation 
The instrumentation of the animals for 
hemodynamic studies was performed one week after the 
last administration of the vehicle (n=5) or doxorubicin 
(n=5), respectively, as previously described (Leite-
Moreira and Correia-Pinto 2001). In summary, animals 
were premedicated with ketamine hydrochloride  
(50 mg kg−1, I.M., Ketalar®, Pfizer Limited) and xylazine 
hydrochloride (5 mg kg−1, I.M., Rompum®, Bayer). 
A femoral vein was cannulated, and a intravenous 
solution containing 20 meq KCl and 40 meq NaHCO3 in 
500 ml of 0.9 % NaCl was administrated at a rate of  
8 ml kg−1 h−1 to compensate for perioperative fluid losses. 
A tracheostomy was performed, and mechanical 
ventilation was initiated (Harvard Small Animal 
Ventilator, model 683), delivering oxygen-enriched air. 
Respiratory rate and tidal volume were adjusted to keep 
arterial blood gases and pH within physiological limits. 
General anesthesia was maintained by intravenous 
infusion of midazolam (0.07 mg kg−1 h−1, Midazolam B. 
Braun), fentanil (0.003 mg kg−1 h−1, Fentanil B. Braun) 
and vecuronium (0.1 mg kg−1 h−1, Norcuron®, Organon) 
to achieve adequate depth of anesthesia for absence of a 
corneal reflex. A 20 gauge catheter was inserted in the 
right femoral artery and connected to a pressure 
transducer to monitor heart rate and arterial pressure and 
to obtain samples for blood gas analysis. The heart was 
exposed by a median sternotomy, and the pericardium 
was opened wide. A limb lead electrocardiogram between 
the left leg electrode and the right arm electrode (DII) 
was recorded throughout. Transient aortic constrictions 
were performed by abruptly occluding the aorta with a 
silk suture placed around the ascending aorta during the 
diastole separating two heartbeats. This was achieved by 
pushing a plastic tube against the aorta with one hand 
while pulling the silk suture with the other hand. Aortic 
constriction was quickly released to avoid neurohumoral 
reflex changes in cardiac function (Correia-Pinto et al. 
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2006). Peak systolic pressure of isovolumetric heartbeats, 
which can be obtained with aortic occlusions, is a 
sensitive index of left ventricular contractility. 
 
Pressure measurements 
Two 3 French high-fidelity micromanometers 
(SPR-524; Millar Instruments, Houston, TX, USA) were 
inserted through an apical puncture wound into the LV 
cavity. One was pulled carefully back towards the 
endocardium and secured in place with a purse-string 
suture to measure apical left ventricular pressure (LVP). 
The other was introduced until we could see the impact 
from the aortic valve on the pressure trace. The catheter 
then was pulled back 3 mm below the aortic valve so that 
it was located in the LV outflow tract to measure basal 
LVP. The pressure transducers were calibrated against a 
mercury column and zeroed after stabilization for 30 min 
in a water bath at body temperature. The zero was set at 
the level of the right atrium. Recordings were made with 
respiration suspended at end expiration. Parameters were 
converted online to digital data with a sampling 
frequency of 1 kHz. Left ventricular pressures were 
measured at end diastole (LVPED), at pressure nadir 
(LVPmin) and at peak systole (LVPmax). Peak rates of LV 
pressure rise (dP/dtmax) and pressure fall (dP/dtmin), as 
well as time to dP/dtmin, were also measured. Relaxation 
rate was estimated with the time constant τ by fitting the 
isovolumetric pressure fall to a monoexponential 
function. We recorded the IVPG continuously as apical 
minus outflow-tract LVP. Peak and average (area divided 
by duration) IVPGs were calculated during diastolic and 
systolic phases of the cardiac cycle. 
 
Sonomicrometry 
Regional ventricular function was measured with 
two pairs of ultrasonic segment length gauges implanted 
in the circumferential direction of apical and basal left 
ventricular anterior midwall and connected to a 
sonomicrometer amplifier system (Triton Technology, 
San Diego, CA, USA). At the end of the experiment, the 
animal was euthanized by administration of an overdose 
of anesthetic agents, and the positions of the crystals and 
micromanometers were verified at postmortem 
examination. Segment lengths were measured at the end 
diastole (ED length), at dP/dtmax and at mitral valve 
opening (MVO). Minimal segment length (Lengthmin) 
was measured as the minimal length preceding or 
coinciding with peak –dP/dtmin. Fractional shortening was 
calculated as the percentage segment length change from 
end diastole to dP/dtmin. 
 
Experimental protocol 
After complete instrumentation, we allowed the 
animal preparation to stabilize for 30 min before the 
beginning of the experimental protocol, which consisted 
in measuring apex to outflow-tract pressure gradients and 
apical and basal myocardial segment lengths in control 
and heart failure animals during baseline and afterloaded 
heartbeats. The animals were not paced, but heart rate did 
not vary significantly during the experimental protocol. 
 
Statistical analysis 
Statistical analysis was performed using 
SPSS 17.0 software. Group data are presented as means ± 
SEM and were compared using two-way ANOVA. 
Student-Newman-Keuls test was selected to perform 
pairwise multiple comparisons when significant 
differences were detected. Statistical significance was 
assumed at a two tailed value of P<0.05. 
 
Results 
 
Cardiac hemodynamics and echocardiography 
The hemodynamic features of the experimental 
groups are summarized in Table 1. In comparison with 
the control group, the heart failure group presented a 
lower systolic pressure, dP/dtmax, peak systolic 
isovolumetric pressure and fractional shortenning. The 
left ventricular filling pressure, as estimated by left 
ventricular end-diastolic pressure, was increased in 
failing hearts, whereas the dP/dtmin was decreased and the 
relaxation time constant τ was increased. Furthermore, 
the echocardiographic evaluation in the heart failure 
group demonstrated a progressive increase of the  
end-diastolic (from 14.2±0.3 to 15.2±0.3 mm) and  
end-systolic (from 9.9±0.2 to 11.1±0.3 mm) short-axis 
diameters and a reduction in fractional shortening (from 
32±1 to 26±1 %) and ejection fraction (from 64±1 to 
56±2 %) of the left ventricle. This was consistent with the 
presence of dilated cardiomyopathy and heart failure. 
Moreover, in the present study the animals had clear 
signs of heart failure such as ruffled hair, labored 
ventilation, ascites and pleural effusion. 
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Table 1. Systolic and diastolic parameters in control and heart failure animals. 
 
 Control Heart failure 
 Apex Outflow tract Apex Outflow tract 
LVPED (mm Hg) 3.3±0.2 3.2±0.3 3.9±0.2α 4.0±0.2α 
dP/dtmax (mm Hg/s) 3791±667 3669±627 1187±182α 1103±155α 
LVPmax (mm Hg) 80.7±4.6 80.8±4.7 49.1±5.5α 48.6±5.1α 
dP/dtmin (mm Hg/s) -3598±664 -4631±564β -1070±241α -1098±234α 
LVPISO (mm Hg/s) 148.9±9.2 149.7±9.8 84.6±13.5α 82.6±11.3α 
Time to dP/dtmin (ms) 140±2 129±1β 191±11α 190±9α 
LVPmin (mm Hg) 2.7±0.6 2.0±1.6 2.9±0.4 3.3±0.5 
Time to LVPmin (ms) 214±8 231±4β 268±9α 272±7α 
τ (ms) 15.0±1.3 10.6±0.6β 30.4±1.9α 28.4±2.2α 
ED length (mm) 6.90±0.33 7.35±0.89 7.33±0.54 7.82±1.22 
Length at dP/dtmax (mm) 6.97±0.27 7.39±0.67 7.44±0.76 7.98±0.79 
Lengthmin (mm) 5.89±0.34 6.28±0.78 6.92±1,38 6.72±1,64 
Time to lengthmin (ms) 213±10 170±16β 268±86α 291±56α 
Length at dP/dtmin (mm) 6.20±0.32 6.32±0.42 6.99±1.22 7.12±0.96 
Length at MVO (mm) 6.00±0.20 6.22±0.23 6.78±0.98 6.98±1.43 
Fractional shortenning (%) 12.7±1.9 14.3±1.1 6.2±2.9α 7.9±1.3α 
Heart rate (bpm) 170±11 181±7 
 
α P<0.05 versus normal; β P<0.05 versus apex. Abbreviations: LVPED, end diastolic left ventricular pressure; dP/dtmax, peak rate of left 
ventricular pressure rise; LVPmax, peak systolic left ventricular pressure; dP/dtmin, peak rate of left ventricular pressure fall; LVPISO, peak 
systolic pressure in a isovolumetric beat; LVPmin, left ventricular pressure nadir; τ, time constant of isovolumetric relaxation rate; ED 
length, end diastolic segment length; Lengthmin, minimal segment length; MVO, mitral valve opening. 
 
 
Table 2. Apex-to-outflow tract mean pressure gradients (in mm Hg) throughout the cardiac cycle at baseline and during afterload 
elevation in control and heart failure animals. 
 
 Diastole Systole 
 
Early  
diastole 
Ventricular 
filling 
Atrial 
contraction 
Rapid  
ejection 
Slow  
ejection 
Control      
Baseline -5.1±0.7 +3.4±0.2 +0.6±0.1 +0.5±0.1 -0.9±0.1 
Afterload -1.5±0.3α +3.7±0.2 +0.5±0.1 -0.8±0.1α -0.9±0.1 
Heart failure      
Baseline -0.5±0.1β +0.1±0.1β +0.4±0.1 +1.0±0.2 +0.7±0.2β 
Afterload -0.5±0.2β +0.1±0.2β +0.4±0.2 +2.3±0.3α,β +1.8±0.3α,β 
 
α P<0.05 versus baseline; β P<0.05 versus control. 
 
 
IVPGs changes in heart failure 
Figure 1 represents left ventricular apical and 
outflow tract pressures, as well as, simultaneous 
recording of the apex-to-outflow tract IVPG along 
cardiac cycle in two representative examples, one of a 
normal and one of a heart failure animal. Table 2 
summarizes mean IVPGs throughout the cardiac cycle in 
control and heart failure animals during baseline and 
afterloaded cardiac beats. 
In healthy hearts of control animals, during the 
rapid phase of ventricular filling, we recorded a  
–5.1±0.5 mm Hg IVPG from the outflow-tract to the 
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apex. Later, when apical pressure started to rise, the 
outflow-tract pressure continued to fall, thus creating a 
+3.6±0.2 mm Hg apex to outflow-tract pressure gradient. 
During systole we recorded a biphasic IVPG pattern, 
manifested as a positive gradient (+0.6±0.1 mm Hg) from 
apex to outflow-tract during rapid ejection, which was 
followed by a negative gradient from the outflow-tract 
to the apex during the slow ejection phase  
(–0.8±0.1 mm Hg).
 
 
Fig. 1. Left ventricular apical (–––) and outflow tract (----) pressures and simultaneous recording of apex-to-outflow tract IVPG (gray) 
along cardiac cycle in a representative normal vs heart failure animal. Normal: During diastole we observed a significant outflow tract-
to-apex IVPG in the early diastole (a) and an apex-to-outflow tract IVPG in the late diastole (b); during early systole we recorded an 
IVPG from apex-to-outflow (c) which inverts during late systole (d). Heart Failure: Diastolic IVPGs observed during normal ventricular 
filling were entirely lost in failing hearts, while during systole we observed only one apex-to-outflow-tract gradient throughout 
ventricular emptying (c’). 
 
 
In failing ventricles of heart failure animals, 
diastolic ventricular filling was delayed and slower, as 
indicated by the increase in times to apical and basal peak 
dP/dtmin and to LVP nadir. Moreover, the nonuniformity 
(measured as distinct timings at which minimum length 
was achieved between different ventricular segments 
during cardiac cycle) observed between apical and basal 
segments in healthy hearts was abolished in heart failure. 
In fact, faster outflow-tract relaxation (assessed by 
dP/dtmin and by the time constant τ) observed in healthy 
hearts was not observed in failing hearts where relaxation 
occurred at the same moment in the apex and in the 
outflow-tract (Table 1, Time to LVPmin). Simultaneously, 
diastolic IVPGs were entirely lost in heart failure 
animals, and no differences were recorded between 
outflow-tract and apical LV pressures during ventricular 
filling (Fig. 1, Heart Failure). During ventricular 
emptying faster contraction of basal in comparison to 
apical myocardial segments recorded in healthy hearts 
(assessed by a shorter time to minimal length for a similar 
myocardial shortening) was also abolished in heart failure 
animals. In failing hearts minimal length occurred later 
and almost at same time both in apical and in basal 
myocardial segments (Table 1, Time to lenghtmin). 
Simultaneously, the physiological biphasic IVPG pattern 
observed in healthy hearts during systole was not 
observed in failing hearts (Fig. 1, Heart Failure). 
Additionally, the response to afterload elevation was also 
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distinct in the failing hearts, which may represent a 
sensitive indicator of LV contractility impairment 
(Table 2). 
 
Discussion 
 
The present study showed that diastolic IVPGs, 
a marker of normal ventricular filling, and systolic 
IVPGs, a marker of normal ventricular emptying, are 
abolished in failing hearts. 
Previously, we demonstrated that diastolic and 
systolic IVPGs are modulated by physiological 
nonuniformity between basal and apical myocardial 
segments and that IVPGs can be attenuated, lost entirely 
or even reversed when ventricular emptying is opposed 
by afterload elevations or after regional acute ischemia 
(Guerra et al. 2013). So, we hypothesized that any 
condition that interferes with the normal segmental 
function, such as chronic heart failure, might be expected 
to alter the physiological IVPGs throughout the cardiac 
cycle. In fact, dilated ventricles are poor suction pumps, 
aspirating a relatively small volume in early filling and 
compensating with atrial contraction and a resting 
tachycardia to maintain cardiac output (Little 2005). 
Healthy ventricles store greater amounts of elastic energy 
during systole and are therefore more effective suction 
pumps during diastole (Gilbert and Glantz 1989). In this 
context, reduced diastolic IVPGs are the consequence not 
only of a lower impulse due to depressed elastic recoil, 
but also of relatively higher deleterious convective forces 
and impaired ventricular relaxation, which adversely 
affect LV filling (Nikolic et al. 1995). 
In our animal model, the progression of cardiac 
dysfunction was monitored echocardiographically to 
estimate morphologic and functional alterations during 
the development of heart failure. Hemodynamic studies 
performed two weeks after the last administration of 
doxorubicin and the last echocardiographic evaluation 
clearly showed the presence of systolic and diastolic 
dysfunction in heart failure animals. In comparison with 
the control group, the heart failure group presented 
significantly lower systolic pressures, dP/dtmax, peak 
systolic isovolumetric pressures and fractional 
shortening, consistent with the presence of dilated 
cardiomyopathy and heart failure. In fact, doxorubicin is 
an anthracycline widely used in cytostatic treatments 
which causes a dose-dependent cardiotoxicity and thus 
has been used to induce heart failure in various animal 
species (Gomes et al. 2012). Doxorubicin-induced 
cardiomyopathy is characterized by ventricular wall 
thinning and dilatation, and depressed systolic and 
diastolic function accompanied by fluid retention and by 
neurohumoral activation (Chekanov 1999). At the cardiac 
muscle level, it promotes intrinsic contractile dysfunction 
and reduced contractile reserve. Furthermore, 
doxorubicin impairs vascular as well as endocardial 
endothelial function and induces inflammatory reactions 
in the heart, leading to thrombosis in the atria and 
myocarditis (Gaudin et al. 1993). Multiple pathways of 
anthracycline-induced cardiac cellular injury have been 
proposed such as the release of cardiotoxic substances, 
which subsequently accumulate in the cardiomyocytes, 
the generation of free radical, lipid peroxidation, and 
suppression of DNA, RNA and protein synthesis (Sawyer 
et al. 2010, Adão et al. 2013). 
In the present study the animals had clear signs 
of heart failure, which were more compatible with the 
invasive hemodynamic measurements than with the  
more modest echocardiographic depression. As 
echocardiographic recordings were performed every two 
weeks, the last echocardiographic evaluation was carried 
out two weeks before the hemodynamic measurements. 
Given the rapid progression of the disease after six 
weeks, this might explain the different phenotypes at the 
two distinct time points. Moreover, echocardiography is 
not a sensitive method for detecting significant 
differences of wall thickening in these small hearts.  
In heart failure animals, the normal base-to-apex 
IVPG observed during early diastole was entirely 
abolished, showing impairment of ventricular filling. Late 
diastolic apex-to-base IVPG was also lost in failing hearts 
which may compromise the beginning of next ventricular 
emptying. In fact, diastolic IVPGs might be causally 
related to recoil of ventricular walls in conjunction with 
release of elastic energy stored during the previous 
systole, which generates suction and contributes to 
normal filling (Courtois et al. 1990). In cardiomyopathic 
hearts, abnormal diastolic movement of dyskinetic 
segments during isovolumetric relaxation could impart 
some motion to blood pooled in the apical and anterior 
regions of the ventricle and thus contribute to the 
alteration of the normal diastolic IVPGs (Beppu et al. 
1988, Delemarre et al. 1988). Moreover, some elastic 
potential energy stored during systole could be 
prematurely lost during early diastole in failing hearts 
which may impair ventricular filling and abolish normal 
early and late diastolic IVPGs (Smiseth et al. 1998). 
Thus, acute or chronic ventricular dysfunction, by 
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diminishing the amount of functional ventricular 
myocardium available for contraction and subsequent 
elastic recoil in one region of the ventricle, should result 
in loss or diminution of the diastolic IVPG in that region 
(Guerra et al. 2013). 
During systole, the normal IVPG pattern 
observed in healthy hearts, and characterized by an apex 
to outflow-tract gradient during rapid ejection followed 
by an outflow-tract to apex gradient during the slow 
ejection phase, was also lost in failing hearts. In normal 
hearts, systolic IVPG pattern parallels the physiological 
aortic-ventricular pressure gradients observed between 
aorta and the LV with aortic pressure being lower than 
LV pressure during rapid ejection and higher during the 
slow ejection phase. In heart failure animals, 
physiological biphasic IVPGs during systole were not 
observed, which may impair normal ventricular 
emptying. 
As a potential limitation, we must acknowledge 
that the present study was performed in anesthetized 
open-chest and open-pericardium animals with two 
pressure catheters tied at the level of the LV apex and two 
myocardial segment length gauges placed in the apex and 
base of the LV free wall. These manipulations may 
impair ventricular contractility, as well as, may alter 
longitudinal function and torsion thereby affecting apex 
to base gradients. We must however underscore that the 
catheters and segment length gauges are rather flexible 
and small, minimizing the negative impact on LV 
function. Moreover, as both groups (heart failure and 
control) were submitted to the same surgical 
manipulation such impact should have been similar, 
therefore making it acceptable to compare IVPGs in the 
two groups (Guerra et al. 2011a).  
In conclusion, regional alterations in IVPGs 
might be an important factor in the characteristic changes 
that occur in intraventricular flow in specific cardiac 
disorders. IVPGs play a physiological role in the healthy 
heart that is lost in pathological conditions, which may 
contribute to and represent an early sign of ventricular 
dysfunction. In this way IVPGs recording and study may 
give important novel insight into the comprehension of 
heart failure pathophysiology. Moreover, our findings 
might be relevant to better understand the 
pathophysiology of doxorubicin-induced cardiomyopathy 
so that we can develop efficient protective and/or 
therapeutic strategies in patients treated with this 
chemotherapeutic agent. 
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